Cargando…

Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.

BACKGROUND: The prevalence of chronic hepatitis C (CHC) in People Who Inject Drugs (PWID) is 8-10% as compared to 3·6% in the general population in Punjab, India. We assessed the real-world efficacy and safety of free-of-charge generic direct-acting antivirals (DAAs), sofosbuvir with an NS5A inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhiman, Radha K., Grover, Gagandeep S., Premkumar, Madhumita, Roy, Akash, Taneja, Sunil, Duseja, Ajay, Arora, Sanjeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529203/ https://www.ncbi.nlm.nih.gov/pubmed/34712928 http://dx.doi.org/10.1016/j.eclinm.2021.101148

Ejemplares similares

Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India
por: Chugh, Yashika, et al.
Publicado: (2021)

Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India
por: Chugh, Yashika, et al.
Publicado: (2019)

CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers
por: Schwarz, Caroline, et al.
Publicado: (2023)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
por: Flisiak, Robert, et al.
Publicado: (2022)

Animal Naming Test – a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy
por: Agarwal, Ankit, et al.
Publicado: (2020)

Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2021)

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates
por: Lens, Sabela, et al.
Publicado: (2022)

Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free
por: Fiore, Vito, et al.
Publicado: (2022)

Monocyte human leukocyte antigen – Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure
por: Satsangi, Sandeep, et al.
Publicado: (2018)

Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
por: Garvey, Lucy J, et al.
Publicado: (2020)

Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
por: Makkar, Kunaal, et al.
Publicado: (2020)

Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY
por: Singh, Virendra, et al.
Publicado: (2022)

Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study
por: Singh, Amandeep, et al.
Publicado: (2022)

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis
por: Marquez, Lara K., et al.
Publicado: (2022)

What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis
por: Skaathun, Britt, et al.
Publicado: (2020)

Feasibility, Outcomes, and Safety of Telehepatology Services During the COVID‐19 Pandemic
por: Verma, Nipun, et al.
Publicado: (2021)

Invasive Pulmonary Aspergillosis and Tuberculosis Complicated by Hemophagocytic Lymphohistiocytosis - Sequelae of COVID-19 in a Liver Transplant Recipient
por: Gandotra, Akash, et al.
Publicado: (2022)

Implementing a Comprehensive Hepatitis C Virus (HCV) Clinic Within a Human Immunodeficiency Virus Clinic: A Model of Care for HCV Microelimination
por: Rizk, Christina, et al.
Publicado: (2019)

Suitability of Tele-consultation for Hepato-biliary Diseases During Covid 19 Pandemic in India: A Machine Learning Based Approach
por: Vojjala, Nikhil, et al.
Publicado: (2022)

Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini‐review of the literature
por: Verma, Nipun, et al.
Publicado: (2017)

Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in India
por: Ghosh, Abhishek, et al.
Publicado: (2022)

Retrieval of HCV patients lost to follow-up as a strategy for Hepatitis C Microelimination: results of a Brazilian multicentre study
por: Ferraz, Maria Lucia Gomes, et al.
Publicado: (2023)

Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding
por: Premkumar, Madhumita, et al.
Publicado: (2022)

An Evaluation of Malaria Surveillance System in Punjab, India, 2020
por: Sharma, Sahil, et al.
Publicado: (2023)

Hepatitis C microelimination among people living with HIV in Taiwan
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Management of Post-Liver-Transplant Delirium with Melatonin: A Case Report
por: Grover, Sandeep, et al.
Publicado: (2020)

People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination
por: Boodram, Basmattee, et al.
Publicado: (2022)

Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF
por: Premkumar, Madhumita, et al.
Publicado: (2021)

Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma
por: Kalra, Naveen, et al.
Publicado: (2017)

Assessment of barriers and motivators to online learning among medical undergraduates of Punjab
por: Kaur, Harjot, et al.
Publicado: (2021)

New Portal Vein Thrombosis in Cirrhosis - is the Thrombophilia Exacerbated due to Vaccine or COVID-19?
por: Premkumar, Madhumita, et al.
Publicado: (2022)

Molecular epidemiology and viral load of HCV in different regions of Punjab, Pakistan
por: Afridi, Suliman Qadir, et al.
Publicado: (2014)

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
por: Schwarz, M., et al.
Publicado: (2023)

Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis()
por: Verma, Nipun, et al.
Publicado: (2023)

Prevention and Management of Bacterial Infections in Cirrhosis
por: Taneja, Sunil K., et al.
Publicado: (2011)

Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study
por: Martínez-Rebollar, María, et al.
Publicado: (2021)

Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study
por: Martínez-Rebollar, María, et al.
Publicado: (2022)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

COVID-19 in Punjab, India: Epidemiological patterns, laboratory surveillance and contact tracing of COVID-19 cases, March–May 2020
por: Sharma, Sahil, et al.
Publicado: (2021)

Toward microelimination of hepatitis C and HIV coinfection in NHS Tayside, Scotland: Real‐world outcomes
por: Byrne, Christopher, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_15h4iij3h9ugkt6u52vnse1ndb